TY - JOUR T1 - The Role of Akt Activation in the Response to Chemotherapy in Pancreatic Cancer JF - Anticancer Research JO - Anticancer Res SP - 3279 LP - 3289 VL - 30 IS - 9 AU - COLIN M. PARSONS AU - DIEGO MUILENBURG AU - TAWNYA L. BOWLES AU - SUBBULAKSHMI VIRUDACHALAM AU - RICHARD J. BOLD Y1 - 2010/09/01 UR - http://ar.iiarjournals.org/content/30/9/3279.abstract N2 - The PI3K/Akt signaling pathway is constitutively activated in some pancreatic cancers; when activated, it inhibits chemotherapy-mediated apoptosis. We examined whether Akt activity correlates with apoptotic resistance to chemotherapy in pancreatic cancer. Materials and Methods: A panel of human pancreatic cancer cells was evaluated for basal Akt activity as well as response to three chemotherapies. Chemotherapy-induced cell death was evaluated following either up- or down-regulation of Akt activity. Evaluation of phosphorylation of p21Cip/Waf1, a downstream target of Akt, was also evaluated. Results: There was a broad distribution among pancreatic cancer cell lines by Akt activity, as well as sensitivity to the three chemotherapeutic agents with no apparent correlation. Phosphorylation of p21Cip/Waf1, but not change in total levels, correlated with the chemosensitizing effect of Akt inhibition to paclitaxel. Conclusions: Basal Akt activity does not appear to be a useful predictor for selection of pancreatic cancers in targeting Akt to broadly induce chemosensitivity. ER -